CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility

A functional polymorphism located at -1 from the start codon of the CD40 gene, rs1883832, was previously reported to disrupt a Kozak sequence essential for translation. It has been consistently associated with Graves' disease risk in populations of different ethnicity and genetic proxies of thi...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 5; no. 7; p. e11520
Main Authors Blanco-Kelly, Fiona, Matesanz, Fuencisla, Alcina, Antonio, Teruel, María, Díaz-Gallo, Lina M, Gómez-García, María, López-Nevot, Miguel A, Rodrigo, Luis, Nieto, Antonio, Cardeña, Carlos, Alcain, Guillermo, Díaz-Rubio, Manuel, de la Concha, Emilio G, Fernandez, Oscar, Arroyo, Rafael, Martín, Javier, Urcelay, Elena
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 12.07.2010
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A functional polymorphism located at -1 from the start codon of the CD40 gene, rs1883832, was previously reported to disrupt a Kozak sequence essential for translation. It has been consistently associated with Graves' disease risk in populations of different ethnicity and genetic proxies of this variant evaluated in genome-wide association studies have shown evidence of an effect in rheumatoid arthritis and multiple sclerosis (MS) susceptibility. However, the protective allele associated with Graves' disease or rheumatoid arthritis has shown a risk role in MS, an effect that we aimed to replicate in the present work. We hypothesized that this functional polymorphism might also show an association with other complex autoimmune condition such as inflammatory bowel disease, given the CD40 overexpression previously observed in Crohn's disease (CD) lesions. Genotyping of rs1883832C>T was performed in 1564 MS, 1102 CD and 969 ulcerative colitis (UC) Spanish patients and in 2948 ethnically matched controls by TaqMan chemistry. The observed effect of the minor allele rs1883832T was replicated in our independent Spanish MS cohort [p = 0.025; OR (95% CI) = 1.12 (1.01-1.23)]. The frequency of the minor allele was also significantly higher in CD patients than in controls [p = 0.002; OR (95% CI) = 1.19 (1.06-1.33)]. This increased predisposition was not detected in UC patients [p = 0.5; OR (95% CI) = 1.04 (0.93-1.17)]. The impact of CD40 rs1883832 on MS and CD risk points to a common signaling shared by these autoimmune conditions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Conceived and designed the experiments: FM EGdlC JM EU. Performed the experiments: FBK AA MT LMDG. Analyzed the data: FBK FM AA MT LMDG MGG MALN LR AN CC GA MDR OF RA JM EU. Contributed reagents/materials/analysis tools: EGdlC EU. Wrote the paper: EU. Revised a draft of the manuscript: FM JM. Diagnosed patients and collected samples: MGG MALN LR AN CC GA MDR OF RA.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0011520